TATVA CHINTAN PHAR...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO TATVA CHINTAN PHAR...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Tatva Chintan Pharma Chem Ltd.

Tatva Chintan Pharma Chem Ltd.

NSE & BSE · Mainboard IPO
Listed NSE & BSE Mainboard Live Chart
Issue Price
₹1,083
₹1,083
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹1,083
Based on GMP
Min. Investment
₹14,079
1 lot × 13 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
16 Jul 2021
Close Date
20 Jul 2021
Allotment
26 Jul 2021
Listing Date
29 Jul 2021
Exchange
NSE & BSE
Price Band
₹1,083
Listing Price
See chart
Allotment Status
Price Band
₹1,083
Per share
Face Value
₹10 per share
 
Lot Size
13 Shares
per lot
Issue Size
46,16,804 shares (aggregating up to ₹500.00 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹14,079
1 lot
Pre-IPO Holding
2,00,87,500 shares
Promoters
Post-IPO Holding
2,21,65,062 shares
Promoters
UPI Deadline
2021-07-20
Mandate
Anchor AllotmentThu, 15 Jul 2021
Basis of AllotmentMon, 26 Jul 2021
Refund InitiationTue, 27 Jul 2021
Demat CreditWed, 28 Jul 2021
Listing DayThu, 29 Jul 2021
UPI Mandate Deadline2021-07-20
Sale TypeFresh Capital-cum-Offer for Sale
Fresh Issue Shares20,77,562 shares (aggregating up to ₹225.00 Cr)
Offer for Sale25,39,242 shares of ₹10 (aggregating up to ₹275.00 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Tatva Chintan Pharma Chem Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 20 Jul 2021.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
4,616,804
100% ₹500.00
IPO Shares Offered
Tatva Chintan Pharma Chem Ltd. IPO total issue size: ₹500.00 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Total 4,616,804 ₹500.00
100.00%
* Based on upper price band ₹1,083 per share
Lot Size & Investment
Lot Size
13
Shares per Lot
Issue Price
₹1,083.00
Upper Band
Min Investment
₹14,079
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)226₹28,158
Retail (Max — 14 Lots)14182₹197,106
S-HNI (Min — 15 Lots)15195₹211,185
B-HNI (Min — 72 Lots)72936₹1,013,688
* Issue Price ₹1,083 × Lot Size 13 shares
IPO Schedule
Anchor
15 Jul 2021
✓ Done
IPO Open
16 Jul 2021
✓ Done
IPO Close
20 Jul 2021
✓ Done
Allotment
26 Jul 2021
✓ Done
Refunds
27 Jul 2021
✓ Done
Demat Credit
28 Jul 2021
✓ Done
Listing Day
29 Jul 2021
✓ Done
Tatva Chintan Pharma Chem Ltd. — Live Price LIVE
₹1,083.00
INR · BSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹1,083.00 Live Price
About Tatva Chintan Pharma Chem Ltd.
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.Competitive strengthsLeading manufacturer of structure directing agents and phase transfer catalyst.Diversified product portfolio.Global market presence with customer base across industries.Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.Experienced promoters and managers team.Strong financial performance track record.
Objects of the Issue
1
1 Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility
2
2 Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and
3
3 General corporate purposes
Tatva Chintan Pharma Chem Ltd. Financials (Amount in Crore)
Revenue from Operations
₹206.8
31-Mar-19
₹264.6
31-Mar-20
₹306.3
31-Mar-21
Profit After Tax (PAT)
₹20.5
31-Mar-19
₹37.8
31-Mar-20
₹52.3
31-Mar-21
Particulars31-Mar-2131-Mar-2031-Mar-19
Revenue from Operations 306.29 264.62 206.80
EBITDA N/A N/A N/A
Profit After Tax (PAT) 52.26 37.79 20.54
Net Worth N/A N/A N/A
Total Assets 314.80 248.94 187.51
Reserves & Surplus N/A N/A N/A
Borrowings N/A N/A N/A
EBITDA Margin (%) N/A
PAT Margin (%) N/A
Issue Structure & Shareholding
Total Shares Offered46,16,804 (100.00%)
Net Offer to PublicN/A
Reserved for Market MakerN/A
Pre-Issue Promoter Holding2,00,87,500 shares
Post-Issue Promoter Holding2,21,65,062 shares
P/BV RatioN/A
RoEN/A
RoCEN/A
Debt / EquityN/A
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
ICICI Securities Ltd.
JM Financial Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Tatva Chintan Pharma Chem Ltd. IPO subscribed?

Tatva Chintan Pharma Chem Ltd. IPO is subscribed 1.00 times by Jul 20, 2021. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Tatva Chintan Pharma Chem Ltd. IPO retail subscription status?

The Tatva Chintan Pharma Chem Ltd. IPO retail category is subscribed 1.00 times as of 20 Jul 2021. The retail portion is oversubscribed.

How to subscribe Tatva Chintan Pharma Chem Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 16 Jul 2021 and closes 20 Jul 2021. Min investment: ₹14,079 (1 lot = 13 shares). UPI mandate: 2021-07-20.

How many times Tatva Chintan Pharma Chem Ltd. IPO subscribed?

The Tatva Chintan Pharma Chem Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Tatva Chintan Pharma Chem Ltd. IPO allotment?

Check allotment on the registrar website (MUFG Intime India Pvt.Ltd.) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 26 Jul 2021. Refunds: on 27 Jul 2021.

When Tatva Chintan Pharma Chem Ltd. IPO will be listed?

The Tatva Chintan Pharma Chem Ltd. IPO listing date is 29 Jul 2021, Thursday. Listed on: NSE & BSE. Issue price: ₹1,083. Estimated listing: ₹1,083. GMP: NIL.

When Tatva Chintan Pharma Chem Ltd. IPO close?

The Tatva Chintan Pharma Chem Ltd. IPO closes on 20 Jul 2021, Tuesday. UPI mandate: 2021-07-20. Allotment: 26 Jul 2021. Listing: 29 Jul 2021.